Apexium Financial’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$56.2K Hold
11,740
﹤0.01% 288
2025
Q2
$28.3K Hold
11,740
﹤0.01% 278
2025
Q1
$30.6K Hold
11,740
﹤0.01% 277
2024
Q4
$44.7K Buy
11,740
+827
+8% +$4.46K ﹤0.01% 258
2024
Q3
$78.2K Hold
10,913
0.01% 233
2024
Q2
$80K Hold
10,913
0.01% 225
2024
Q1
$109K Sell
10,913
-4,955
-31% -$43.4K 0.01% 223
2023
Q4
$111K Sell
15,868
-19,534
-55% -$130K 0.01% 266
2023
Q3
$281K Sell
35,402
-4,498
-11% -$28.4K 0.03% 178
2023
Q2
$221K Sell
39,900
-6,349
-14% -$34.8K 0.02% 200
2023
Q1
$263K Buy
46,249
+38
+0.1% +$252 0.03% 183
2022
Q4
$323K Buy
46,211
+2,203
+5% +$22.7K 0.03% 161
2022
Q3
$392K Buy
+44,008
New +$508K 0.05% 136

Other funds holding MSOS

Apexium Financial's MSOS Position: Q3 2025 in Review

Apexium Financial held its AdvisorShares Pure US Cannabis ETF (MSOS) position steady in Q3 2025 at 11,740 shares worth $56.2K. The position accounts for ﹤0.01% of the portfolio, ranked #288.

Apexium Financial first reported a position in MSOS in Q3 2022 and has held it in 13 quarters since. The position peaked at $392K in Q3 2022. 171 funds tracked by Wall St. Rank hold MSOS as of Q3 2025.

  • Apexium Financial held 11,740 shares of AdvisorShares Pure US Cannabis ETF worth $56.2K as of Q3 2025.
  • Apexium Financial left its AdvisorShares Pure US Cannabis ETF share count unchanged in Q3 2025.
  • AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Apexium Financial's portfolio in Q3 2025, its #288 holding.
  • Apexium Financial first reported a position in AdvisorShares Pure US Cannabis ETF in Q3 2022 and has held it in 13 quarters since.
  • Apexium Financial's AdvisorShares Pure US Cannabis ETF position peaked at $392K in Q3 2022.
  • 171 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2025.

Based on Apexium Financial's 13F filing for Q3 2025, filed 18 Nov 2025.